Rhabdomyosarcoma is a type of soft tissue sarcoma that typically affects children and young adults. A 2018 study in the Journal of Neurological Surgery explored risk stratification methods for rhabdomyosarcoma to help guide treatment decisions. The study examined using criteria such as tumor size, location, and stage to determine low, intermediate, or high risk groups for rhabdomyosarcoma patients. Stratifying patients into risk groups allows doctors to tailor therapy to a patient's individual risk level.

1. DR KANHU CHARAN PATRO
M.D, D.N.B[RT], FAROI, MBA, PDCR, CEPC
NOVEMBER 2021 ISSUE/68th VOLUME
https://www.facebook.com/oncologycartoons/photos/?tab=album&ref=page_internal
FACE BOOK PAGE
ONCOLOGY CARTOON
PHOTOS
CHAPTER WISE

12. 24th OCT 2021/SARCOMA
Dana L./Journal of Neurological
Surgery/2018
RHABDOMYOSARCOMA RISK STRATIFICATION